Episode 30: ProMIS Neurosciences Chairman and CEO Eugene Williams on Developing Treatments for Alzheimer’s

ProMIS Neurosciences Inc. (NASDAQ: PMN | TSX: PMN) Chairman and CEO Eugene Williams talks to Global One Media to share the science behind targeting misfolded proteins to develop treatments for Alzheimer's disease, amyotrophic lateral sclerosis, multiple system atrophy, and other neurologic disorders. Williams also shares their exciting collaborations and partnerships to further advance the treatments in the life science sector.